|
Disclosures: Paid consultant-Dompe (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-TECLens|Stocks or stock options, excluding diversified mutual funds-Simple Contacts|Paid consultant-Cloudbreak Pharma (Relationship has ended) - 10/10/2022 No Bio Available.
|